Melogliptin - CAS 868771-57-7

Melogliptin, also known as EMD-675992 and GRC-8200, is a potent and selective a dipeptidyl peptidase IV (DPP-IV) inhibitor potentially for treatment of type II diabetes. Melogliptin significantly reduced HbA1c from baseline as compared to placebo with a mean average reduction of 0.75 percent in patients receiving 50mg twice daily dose and 0.60 percent in patients receiving 100 mg once daily dose.

Others

Others

868707

C15H21FN6O

320.37

C(CN[C@H]1C[C@@H](CN2C=NC=N2)CC1)(=O)N3[C@H](C#N)C[C@H](F)C3

-20°C

Ice Packs

Small Compound